Advertisement

What are IL-17 inhibitors?

Donna Hill Howes, RN
Family Practitioner

The drugs secukinumab (Cosentyx) and ixekizumab (Taltz) block certain immune system proteins (IL-17A) that can cause inflammation and psoriasis symptoms. They are approved for people with moderate-to-severe plaque psoriasis. They are given as injections, 1 or more weeks apart. The shots can be given by a doctor or people can give them to themselves.

This answer was adapted from Sharecare's award-winning AskMD app. Start a consultation now to find out what's causing your symptoms, learn how to manage a condition, or find a doctor.

Continue Learning about Plaque Psoriasis

My Story, My Diagnosis: Toni's Story
My Story, My Diagnosis: Toni's Story
When she was eight years old, Toni was diagnosed with psoriasis. As an adult, she was diagnosed with psoriatic arthritis. In this video, she shares he...
Read More
How common is psoriasis?
Sigma NursingSigma Nursing
Psoriasis is a fairly common skin condition. In the United States alone, it's believed that there ar...
More Answers
6 Psoriasis Self-Care Tips You Should Try
6 Psoriasis Self-Care Tips You Should Try6 Psoriasis Self-Care Tips You Should Try6 Psoriasis Self-Care Tips You Should Try6 Psoriasis Self-Care Tips You Should Try
Find out how you can manage your psoriasis on a daily basis.
Start Slideshow
Why May I Need Phototherapy for Psoriasis?
Why May I Need Phototherapy for Psoriasis?

Important: This content reflects information from various individuals and organizations and may offer alternative or opposing points of view. It should not be used for medical advice, diagnosis or treatment. As always, you should consult with your healthcare provider about your specific health needs.